Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis

Parker, 1954, The liver and ulcerative colitis, Br Med J, 2, 1030, 10.1136/bmj.2.4895.1030 Rosen, 1991, Cholangiocarcinoma complicating primary sclerosing cholangitis, Semin Liver Dis, 11, 26, 10.1055/s-2008-1040419 Rosen, 1991, Cholangiocarcinoma complicating primary sclerosing cholangitis, Ann Surg, 213, 21, 10.1097/00000658-199101000-00004 Wiesner, 1989, Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis, Hepatology, 10, 430, 10.1002/hep.1840100406 Farrant, 1991, Natural history and prognostic variables in primary sclerosing cholangitis, Gastroenterology, 100, 1710, 10.1016/0016-5085(91)90673-9 Dickson, 1992, Primary sclerosing cholangitis: refinement and validation of survival models, Gastroenterology, 103, 1893, 10.1016/0016-5085(92)91449-E Stieber, 1989, Cholangiocarcinoma in sclerosing cholangitis: the role of liver transplantation, Int Surg, 74, 1 Miros, 1991, Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis before transplantation, Gut, 32, 1369, 10.1136/gut.32.11.1369 Marsh, 1988, Orthotopic liver transplantation for primary sclerosing cholangitis, Ann Surg, 207, 21, 10.1097/00000658-198801000-00005 O'Grady, 1988, Liver transplantation for malignant disease, 207, 373 Venu, 1988, Endoscopic retrograde brush cytology, 99, 1475 Rabinowitz, 1990, Diagnostic value of brush cytology in the diagnosis of bile duct carcinoma: a study in 65 patients with bile duct strictures, Hepatology, 12, 747, 10.1002/hep.1840120421 Kurzawinski, 1992, A prospective controlled study comparing brush and bile exfoliative cytology for diagnosing bile duct strictures, Gut, 33, 1675, 10.1136/gut.33.12.1675 Steinberg, 1986, Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas, Gastroenterology, 90, 343, 10.1016/0016-5085(86)90930-3 Itzkowitz, 1986, New carbohydrate tumor markers, Gastroenterology, 90, 491, 10.1016/0016-5085(86)90954-6 Steinberg, 1990, The clinical utility of the CA19-9 tumour associated antigen, Am J Gastroenterol, 85, 350 Chapman, 1980, Primary sclerosing cholangitis: a review of its clinical features, cholangiography and hepatic histology, Gut, 21, 870, 10.1136/gut.21.10.870 Lindsell, 1990, Ultrasound imaging of the pancreas and biliary tract, Lancet, 335, 390, 10.1016/0140-6736(90)90217-S MacCarty, 1985, Cholangiocarcinoma complicating primary sclerosing cholangitis: cholangiographic appearances, Radiology, 156, 43, 10.1148/radiology.156.1.2988012 Safi, 1986, Ca19-9 and pancreatic adenocarcinoma, Cancer, 57, 779, 10.1002/1097-0142(19860215)57:4<779::AID-CNCR2820570417>3.0.CO;2-C Ritts, 1984, Inititial clinical evaluation of an immunoradiometric assay for CA19/9 using the NCl serum bank, Int J Cancer, 33, 339, 10.1002/ijc.2910330310 Ramage, 1989, Are serum values of tumour markers useful clinically in predicting the presence of pancreatic malignancy (abstr)?, Gut, 30, A1507 Yamaguchi, 1988, Cancer of the extrahepatic bile duct: a clinicopathologic study of immunohistochemistry for CEA, CA19-9 and p21, World J Surg, 12, 11, 10.1007/BF01658480 Ker, 1991, Assessment of serum and bile levels of CA19-9 and CA-125 in cholangitis and bile duct carcinoma, J Gastroenterol Hepatol, 6, 505, 10.1111/j.1440-1746.1991.tb00896.x Nichols, 1993, Diagnostic role of serum CA19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis, Mayo Clin Proc, 68, 874, 10.1016/S0025-6196(12)60696-X Rogers, 1994, Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis: an analysis of the serological marker CA19-9, Hepatology, 19, 543, 10.1002/hep.1840190239